Facebook Pixel

Medtronic Completes Follow up in Arctic Front® Cryoballoon Clinical Trial for Paroxysmal Atrial Fibrillation

 
Rate This

Medtronic has completed 12 months of follow up in their U.S.-based STOP-AF clinical trial (Sustained Treatment of Paroxysmal Atrial Fibrillation) for treatment of paroxysmal atrial fibrillation. This trial evaluated their cryoballoon catheter, the Arctic Front® CryoAblation Catheter System, which is already approved for use in Europe, Australia and Hong Kong.

Learn more: Medtronic Clinical Trial Evaluating the Industry's First Cryoballoon Technology Designed for Paroxysmal Atrial Fibrillation Completes Follow Up

Mellanie True Hills Bio: https://www.empowher.com/users/mellanie-true-hills

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Atrial Fibrillation

Get Email Updates

Atrial Fibrillation Guide

Have a question? We're here to help. Ask the Community.

ASK

Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!